Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.84 USD | +1.07% | -6.58% | -37.58% |
05-14 | Conduit Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
03-19 | Conduit Pharmaceuticals Inc. Appoints Joanne Holland as Chief Scientific Officer | CI |
Business Summary
Number of employees: 7
Managers
Managers | Title | Age | Since |
---|---|---|---|
David Tapolczay
CEO | Chief Executive Officer | 64 | 23-09-21 |
Adam Sragovicz
DFI | Director of Finance/CFO | 55 | 21-09-30 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Freda Lewis-Hall
CHM | Chairman | 69 | 23-09-21 |
Director/Board Member | 50 | 23-09-21 | |
Faith Charles
BRD | Director/Board Member | 62 | 23-09-21 |
Andrew Regan
BRD | Director/Board Member | 59 | 23-09-21 |
David Tapolczay
CEO | Chief Executive Officer | 64 | 23-09-21 |
Chele Farley
BRD | Director/Board Member | 56 | 23-09-21 |
James Bligh
BRD | Director/Board Member | 36 | 23-09-21 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 73,829,536 | 9,928,091 ( 13.45 %) | 0 | 13.45 % |
Company contact information
Conduit Pharmaceuticals, Inc.
4995 Murphy Canyon Road Suite 300
92123, San Diego
+
http://www.conduitpharma.comSector
1st Jan change | Capi. | |
---|---|---|
-37.58% | 210M | |
+51.85% | 57.87B | |
+41.42% | 40.25B | |
-5.25% | 39.94B | |
-5.16% | 28.54B | |
+12.79% | 26.4B | |
-20.18% | 19.33B | |
+30.88% | 12.4B | |
+0.61% | 12.23B | |
+25.06% | 12.2B |
- Stock Market
- Equities
- CDT Stock
- Company Conduit Pharmaceuticals Inc.